Cleared Abbreviated

vRad PACS with Mammography (K162145) - FDA 510(k) Clearance

Class II Radiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K162145 · Virtual Radiologic Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
85d
Days
Class 2
Risk

K162145 is an FDA 510(k) clearance for the vRad PACS with Mammography. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Virtual Radiologic Corporation (Eden Prairie, US). The FDA issued a Cleared decision on October 25, 2016 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Incremental AI imaging tool. Standards-verified equivalence. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Virtual Radiologic Corporation devices

Submission Details

510(k) Number K162145 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2016
Decision Date October 25, 2016
Days to Decision 85 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 107d · This submission: 85d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 800
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K162145.
NobelClinician, DTX Studio implant
K163122 · Nobel Biocare AB · Jan 2017
syngo.via MI Workflows
K163421 · Siemens Medical Solutions USA, Inc. · Jan 2017
syngo Application Software
K162541 · Siemens Medical Solutions USA, Inc. · Nov 2016
Scenium
K162339 · Siemens Medical Solutions USA, Inc. · Sep 2016
Senolris
K160937 · Ge Healthcare · Aug 2016
DICOM Viewer
K153653 · Brainlab AG · Apr 2016